ArticleNeuropsychiatric disease and treatment2022

Impact of COVID-19 Pandemic on Prescribing of Long-Acting Injectable Antipsychotics for Schizophrenia: Results from a United States Prescriber Survey.

Maryia Zhdanava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.